Sabin is part of the Dengue Vaccine Initiative (DVI), a consortium of organizations working to lay the groundwork for dengue vaccine introduction in endemic areas so that, once licensed, vaccines to prevent dengue will be swiftly adopted. A collaboration between Sabin, the International Vaccine Institute (IVI), the International Vaccine Access Center at the Johns Hopkins University (IVAC), and the World Health Organization (WHO), DVI works to support improved diagnosis, surveillance and development of vaccines to control dengue. 

Photo by James Gathany